1. Home
  2. IVVD vs DUOT Comparison

IVVD vs DUOT Comparison

Compare IVVD & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.82

Market Cap

219.9M

Sector

Health Care

ML Signal

HOLD

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$9.04

Market Cap

261.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
DUOT
Founded
2020
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
219.9M
261.2M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
IVVD
DUOT
Price
$0.82
$9.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.75
★ $17.00
AVG Volume (30 Days)
★ 4.9M
577.2K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.02
53.96
EPS
N/A
★ 1.37
Revenue
★ $53,426,000.00
$27,023,651.00
Revenue This Year
$61.57
$50.98
Revenue Next Year
$41.42
N/A
P/E Ratio
★ N/A
$6.56
Revenue Growth
110.47
★ 271.16
52 Week Low
$0.53
$6.17
52 Week High
$3.07
$15.28

Technical Indicators

Market Signals
Indicator
IVVD
DUOT
Relative Strength Index (RSI) 47.06 50.34
Support Level $0.72 $8.02
Resistance Level $1.02 $9.52
Average True Range (ATR) 0.09 0.39
MACD 0.00 0.09
Stochastic Oscillator 28.19 61.65

Price Performance

Historical Comparison
IVVD
DUOT

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.

Share on Social Networks: